Report Overview
Sildenafil is a pharmaceutical compound primarily used to treat erectile dysfunction (ED) and pulmonary arterial hypertension (PAH).
It belongs to a class of drugs known as phosphodiesterase type 5 (PDE5) inhibitors, which work by relaxing blood vessels and improving blood flow to specific areas of the body. Originally developed by Pfizer, Sildenafil gained worldwide recognition under the brand name Viagra.
Over the years, generic versions of the drug have been introduced by various pharmaceutical companies, making it more accessible to consumers globally.
Market Analysis
The global Sildenafil Marketwas valued at US$ 1.85 billion in 2024 and is projected to reach US$ 2.94 billion by 2032, exhibiting a CAGR of 5.4% during the forecast period (2025-2032).
This growth is driven by increasing demand for ED treatment, rising cases of PAH, and the growing elderly population worldwide.
The market has seen significant expansion due to wider product availability through hospital pharmacies, retail pharmacies, and online pharmacies.
